KalVista Pharmaceuticals (KALV) Price to Sales (2016 - 2026)
KalVista Pharmaceuticals (KALV) Price to Sales (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
P/S |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
44.65 Mn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3,489.70 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
41.13 |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
9.26 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
17,434.90 |
| 10 |
KalVista Pharmaceuticals |
1.44 Bn |
1.25 Bn |
56.41 Mn |
20.10 |
| Date | Value |
|---|
| Jun 10, 2026 |
20.10 |
| Jun 9, 2026 |
20.10 |
| Jun 8, 2026 |
20.10 |
| Jun 5, 2026 |
20.07 |
| Jun 4, 2026 |
20.07 |
| Jun 3, 2026 |
20.07 |
| Jun 2, 2026 |
20.07 |
| Jun 1, 2026 |
20.07 |
| May 29, 2026 |
20.01 |
| May 28, 2026 |
19.94 |
| May 27, 2026 |
19.95 |
| May 26, 2026 |
19.96 |
| May 22, 2026 |
19.95 |
| May 21, 2026 |
19.95 |
| May 20, 2026 |
19.97 |
| May 19, 2026 |
19.93 |
| May 18, 2026 |
19.92 |
| May 15, 2026 |
19.91 |
| May 14, 2026 |
19.94 |
| May 13, 2026 |
19.96 |
